UK’s NICE to launch sweeping changes to drug assessments to be faster, more agile

19 January 2022 - The health technology assessment body has been under pressure from drugmakers and patient groups for years to ...

Read more →

NICE launches ambitious strategy to provide quicker access to new treatments and innovations

19 April 2021 - NICE will transform key elements of its approach to ensure efficiency and speed while maintaining robust, trusted ...

Read more →

NICE methods and process review aims to create fertile ground for innovation

29 March 2021 - The way NICE reviews new medicines is about to go through its biggest change in years – ...

Read more →

NICE to make changes to health technology evaluation

26 June 2019 - The Voluntary Scheme for Branded Medicines Pricing and Access, agreed by government and the ABPI in ...

Read more →

Evidence required by heath technology assessment and reimbursement bodies evaluating diagnostic or prognostic algorithms that include omics data

23 August 2018 - Multi-analyte assays with algorithmic analyses use combinations of circulating and clinical markers including omics-based sources for diagnostic ...

Read more →